Resident 3 missed pain medication patches on two consecutive days. The lidocaine patches, prescribed to manage pain, were supposed to be applied daily starting August 27 at 9 a.m. Medication administration records showed the resident received nothing on August 27 or August 28.
The same resident also went without psoriasis treatment. Betamethasone cream was ordered every eight hours starting August 26 at 5 p.m. Records showed the resident missed the evening dose on August 26, then missed both morning and midday doses on August 27 and August 28.
Most critically, Resident 3 didn't receive thyroid medication on August 31. The levothyroxine prescription was meant to treat hypothyroidism, a condition where the thyroid gland cannot meet the body's needs. The 50-microgram dose was scheduled for 6 a.m.
During interviews on September 2, the facility's Infection Preventionist confirmed that all three residents identified in the complaint had missed medication doses in August 2025.
The facility had clear procedures for handling missing medications. Licensed nurses were expected to check the emergency medication stock first, then call the pharmacy to confirm delivery times. If medications weren't immediately available, nurses were supposed to contact the prescribing physician to discuss substitutes or whether delays were medically acceptable.
None of this happened.
The Infection Preventionist reviewed progress notes for all three residents and found no documentation that pharmacy or physician calls were made. Nurses had simply allowed the medication schedules to lapse without intervention.
The emergency medication stock contained lidocaine patches. The Infection Preventionist confirmed that Resident 3's pain medication could have been administered from the facility's own supply, yet wasn't.
"The pharmacy was located close by so most medications could be delivered the same day," the Infection Preventionist explained during the September 2 interview. Orders placed during daytime hours typically arrived within hours. Even overnight orders would be delivered the following morning.
The acting Director of Nursing acknowledged the severity during a September 2 interview with the Administrator. Missing any prescribed medication constituted a medication error and "could have negatively affected the health of the residents."
Resident 3's case illustrated the compounding nature of the failures. The thyroid medication miss on August 31 was particularly concerning given the critical role of levothyroxine in regulating metabolism and energy levels. Hypothyroidism patients depend on consistent daily dosing to maintain proper hormone levels.
The psoriasis cream misses created their own cascade of problems. The condition requires consistent topical treatment every eight hours to control inflammation and skin symptoms. Missing multiple consecutive doses over three days likely caused symptom flareups and patient discomfort.
Pain management failures affected quality of life most immediately. Lidocaine patches provide localized pain relief for chronic conditions. When Resident 3 went two full days without the prescribed patches, they experienced unnecessary pain that could have been prevented with basic medication management.
The facility's own policy, revised in April 2019, required that "medications are administered in accordance with prescriber orders, including any required time frame." The policy's language was unambiguous about timing requirements.
Yet the September inspection revealed systematic breakdown in medication administration across multiple residents and drug types. The failures weren't isolated incidents involving a single nurse or shift, but represented broader problems with medication management protocols.
Federal inspectors classified the violations as having potential for actual harm to some residents. The designation reflected the medical risks created when prescribed medications are simply not administered as ordered.
The Infection Preventionist's review of August medication records revealed the scope of the problem extended beyond the three residents specifically cited in the complaint investigation. The systematic nature of the medication administration failures suggested deeper issues with nursing supervision and pharmaceutical management.
Resident 3 remained at the facility during the September investigation, continuing to require the same medications that had been missed in August. The thyroid condition requiring levothyroxine is typically lifelong, making consistent administration critical for ongoing health maintenance.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Santa Rosa Post Acute from 2025-09-02 including all violations, facility responses, and corrective action plans.